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Abstract
Introduction: Serum lactate level may correlate with no-flow and low-flow status during cardiac arrest. Current
guidelines have no recommended durations for cardiopulmonary resuscitation (CPR) before transition to the next
strategy. We hypothesized that the lactate level measured during CPR could be associated with the survival
probability and accordingly be useful in estimating the optimal duration for CPR.
Methods: We conducted a retrospective observational study in a single medical centre and included adult patients
who had suffered an in-hospital cardiac arrest between 2006 and 2012. We used multivariable logistic regression
analysis to study the association of lactate level measured during CPR and outcomes. We used generalized additive
models to examine the nonlinear effects of continuous variables and conditional effect plots to visualize the
estimated survival probability against CPR duration.
Results: Of the 340 patients included in our analysis, 50 patients (14.7 %) survived to hospital discharge. The mean
lactate level was 9.6 mmol/L and mean CPR duration was 28.8 min. There was an inverse near-linear relationship
between lactate level and probability of survival to hospital discharge. A serum lactate level <9 mmol/L was
positively associated with patient survival to hospital discharge (odds ratio 2.00, 95 % confidence interval 1.01-4.06).
The optimal CPR duration may not be a fixed value but depend on other conditions.
Conclusions: Serum lactate level measured during CPR could correlate with survival outcomes. A lactate level
threshold of 9 mmol/L may be used as a reference value to identify patients with different survival probabilities and
determine the optimal CPR durations.
Introduction
More than 200,000 hospitalized adult patients experi-
ence in-hospital cardiac arrest (IHCA) annually in the
USA with an estimated incidence of 1.6 per 1,000 hos-
pital admissions [1]. The survival rate from IHCA has
increased over the past decade [2], probably due to earlier
recognition of cardiac arrest, higher quality of cardiopulmo-
nary resuscitation (CPR), and improved post-resuscitation
care [3, 4]. Despite this progress, mortality following IHCA
remains high, with only about 18 % of patients surviving to
hospital discharge [1].
The causes of high mortality could be due to the
inability to establish rapid return of spontaneous circu-
lation (ROSC) leading to subsequent multi-organ failure.
Extracorporeal CPR (ECPR) has been advocated as a
novel alternative for cardiac arrests that are considered
refractory to initial conventional CPR [5, 6], especially
for IHCA [7]. Nevertheless, the term, “refractory cardiac
arrest,” is ill-defined. Most studies on ECPR have used
CPR duration as an indicator of futile resuscitation,
which varied from 10 to 15 minutes [7–9] and led to
initiation of ECPR within 30 to 60 minutes of CPR.
However, using CPR duration alone may not be an
accurate indicator for estimating survival probability and
determination of futile CPR. Matos et al. [10] reported
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that even in the case of equivalent CPR durations, the
survival probability still differed greatly between differ-
ent patient groups. Although studies have suggested that
the greater the time prior to initiation of ECPR, the
poorer the outcome [7], few studies have been carried
out on the optimal transition time to consider alterna-
tive resuscitation methods in patients with potentially
prolonged CPR. Therefore, finding additional parameters
besides CPR duration to assist clinicians in more accur-
ately estimating the survival probability during CPR
could help strike a balance between optimizing patient
outcomes and avoiding the misuse of scarce critical care
medical resources, such as ECPR.
Weil et al. [11] found that serum lactate level mea-
sured within 10 minutes of CPR could serve as a sensi-
tive indicator of prognosis. A higher post-ROSC serum
lactate level [12–16] or a slower clearance rate of serum
lactate after ROSC [12, 17, 18] has also been shown to
correlate with poor outcomes after cardiac arrest. We
therefore hypothesized that the serum lactate level mea-
sured during CPR may be associated with the survival
probability and accordingly be useful in estimating the




We carried out a retrospective cohort study in a tertiary
medical centre, National Taiwan University Hospital
(NTUH). Before data collection, the Research Ethics
Committee of the National Taiwan University Hospital
approved this study (reference number: 201505161RIN)
and waived the requirement for written informed con-
sent. The NTUH has 2,600 beds, including 220 beds in
intensive care units (ICUs). According to hospital policy,
a code team is activated when cardiac arrest events
occur in the general wards. Each code team member has
been certified to provide advanced cardiac life support.
For cardiac arrest events in the ICUs, resuscitation is
performed by the staff of the ICU where the cardiac ar-
rest events have occurred and by staff from neighbour-
ing ICUs.
Participants
We included patients who had experienced an IHCA at
the NTUH between 2006 and 2012. We used the follow-
ing inclusion criteria: (1) age ≥18 years; (2) documented
absence of pulse with performance of chest compression
for ≥2 minutes; (3) without do-not-resuscitate order; and
(4) serum lactate level measured during the initial 10 mi-
nutes of CPR. If multiple cardiac arrest events occurred
in a single patient, we only recorded the first event of
the same hospitalization. We excluded patients who had
suffered a cardiac arrest related to major trauma.
Data collection and outcome measures
We recorded the following information for each patient:
demographics, comorbidities, variables derived from the
Utstein template [19], the first serum lactate level mea-
sured during CPR, and any critical intervention that was
implemented. CPR duration was defined as the time
from the first chest compression provided by the code
team or ICU members to the termination of resuscitation
efforts, either due to ROSC or declaration of death. The
definitions of comorbidities are appended in Additional
file 1: Table S1.
The primary outcome was survival to hospital discharge.
Secondary outcomes included 10-minute ROSC, defined
as ROSC within 10 minutes of CPR, and favourable neu-
rological status at hospital discharge, defined as a score of
1 or 2 on the cerebral performance category (CPC) scale
[20]. The CPC score was retrospectively determined by
reviewing medical records for each patient.
Statistical analysis
We used R 2.15.3 software (R Foundation for Statistical
Computing, Vienna, Austria) for data analysis. Categorical
data were expressed as counts and proportions; conti-
nuous data were expressed as means and standard devia-
tions. Categorical variables were compared by the Fisher’s
exact test, and continuous variables were examined by the
Wilcoxon rank-sum test. A two-tailed p value of ≤0.05
was considered statistically significant.
We selected the odds ratio as the outcome measure.
We conducted a multivariable logistic regression analysis
to examine the association between independent vari-
ables and outcomes. All available variables were consid-
ered in the regression model, regardless of whether they
were significant by univariate analysis. The stepwise vari-
able selection procedure (with iterations between the
forward and backward steps) was applied to obtain the
final regression model. Significance levels for entry and
for stay were set at 0.15 to avoid exclusion of potential
candidate variables. The final regression model was identi-
fied by excluding individual variables with a p value >0.05,
until all regression coefficients were statistically signifi-
cant. If the lactate level was excluded during the variable
selection procedure, we would re-enter it into the final
model to obtain the effect estimate.
We used generalized additive models (GAMs) [21] to
examine the nonlinear effects of continuous variables
and, if necessary, to identify the appropriate cutoff point(s)
for dichotomizing a continuous variable during the vari-
able selection procedure. We used conditional effect plots
to visualize the predicted probability of survival to hospital
discharge against CPR duration, while maintaining the
other independent variables in the final model constant.
Based on the conditional effect plot, we used CPR dur-
ation of 30 minutes and probability of survival of 18 % [1]
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as reference to calculate the corresponding probabilities of
survival and CPR duration, respectively, for each group of
patients.
We assessed the goodness-of-fit of the fitted regres-
sion model using c statistics (the estimated area under
the receiver operating characteristic curve), adjusted
generalized R2, and the Hosmer-Lemeshow goodness-
of-fit test.
Results
A total of 1,123 adult patients received chest compres-
sion ≥2 minutes in the period between 2006 and 2012.
Of these, only 349 patients had concomitant measure-
ments of serum lactate level during the initial 10 minutes
of CPR. Nine patients were excluded due to trauma-
related cardiac arrest. The remaining 340 patients were
included for further analysis.
The characteristics of the patients included in this
study, stratified by primary outcome, are outlined in
Tables 1 and 2. The mean age of the patients was
65.9 years. A total of 151 cardiac arrest events (44 %) oc-
curred in the ICUs and 171 cardiac arrest events (50 %)
occurred in the general wards. Shockable rhythms repre-
sented 14 % of initial arrest rhythms. The mean lactate
level was 9.6 mmol/L and the mean CPR duration was
28.8 minutes. Both lactate levels and CPR durations
were significantly different between survivors and non-
survivors. There were 242 patients (71 %) who achieved
ROSC and 76 of these patients (22 %) achieved a 10-
minute ROSC. Only 50 patients (15 %) survived to
hospital discharge and 21 of these patients (6 %) displayed
a favourable neurological status.
All variables listed in Tables 1 and 2 were included in
the variable selection procedure for the primary out-
come. The GAM plot revealed a near-linear association
between logit (p), where p represented the probability for
survival to hospital discharge, and lactate level (Additional
file 2: Figure S1). If logit (p) was ≥0, the odds for survival
would be ≥1. Therefore, 9 mmol/L of lactate was selected
as the cutoff point to transform the lactate level into a bin-
ary variable. The characteristics and outcomes of patients
in this study, stratified by lactate level, are reported in
Additional file 3: Table S2, Additional file 4: Table S3, and
in Table 3.
The final regression model is shown in Table 4. Shock-
able rhythm/lactate level <9 mmol/L was positively asso-
ciated with survival to hospital discharge, and hepatic
insufficiency/CPR duration was inversely associated with
survival to hospital discharge. The association between
CPR duration and estimated survival probability for
Table 1 Baseline characteristics of study patients stratified by survival outcome
Variables All patients Patients surviving to hospital discharge Death at hospital discharge P value
(n = 340) (n = 50) (n = 290)
Age, y, mean (SD) 65.9 (16.2) 65.2 (16.2) 66.0 (16.2) 0.75
Male, n (%) 214 (63) 37 (74) 177 (61) 0.08
Comorbidities, n (%)
Heart failure 93 (27) 17 (34) 76 (26) 0.30
Myocardial infarction 45 (13) 9 (18) 36 (12) 0.27
Arrhythmia 55 (16) 11 (22) 44 (15) 0.22
Hypotension 68 (20) 8 (16) 60 (21) 0.57
Respiratory insufficiency 236 (69) 34 (68) 202 (70) 0.87
Renal insufficiency 138 (41) 22 (44) 116 (40) 0.64
Hepatic insufficiency 64 (19) 4 (8) 60 (21) 0.03
Metabolic or electrolyte abnormality 66 (19) 9 (18) 57 (20) 1
Diabetes mellitus 112 (33) 23 (46) 89 (31) 0.05
Baseline evidence of motor, cognitive,
or functional deficits
63 (19) 12 (24) 51 (18) 0.32
Acute stroke 16 (5) 3 (6) 13 (5) 0.71
Favorable neurological status 24 hours
before cardiac arrest
143 (42) 25 (50) 118 (41) 0.28
Pneumonia 111 (33) 19 (38) 92 (32) 0.42
Metastatic cancer or any blood-borne
malignancy
68 (20) 6 (12) 62 (21) 0.18
SD standard deviation
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different patient groups is illustrated in Fig. 1. With refer-
ence to Fig. 1, we calculated the survival probability when
CPR was performed for 30 minutes for each patient group.
We also calculated the CPR duration when survival prob-
ability dropped to 18 % or when survival probability was
half the initial probability (Table 5).
For secondary outcomes, a lactate level <9 mmol/L
was positively associated with a 10-minute ROSC but
not significantly associated with neurological outcome
(Additional file 5: Table S4).
Discussion
In this retrospective observational study, results have
indicated that the serum lactate level measured during
CPR correlated with the outcome of survival to hospital
discharge for IHCA. A serum lactate level <9 mmol/L
within 10 minutes of CPR initiation was positively asso-
ciated with survival. Moreover, together with other vari-
ables, the serum lactate level could be useful in estimating
optimal CPR durations before transition to next strategy
for different patient groups, which could help clinicians
Table 2 Features of cardiac arrest events stratified by survival outcome
Variables All patients Patients surviving to hospital discharge Death at hospital discharge P value
(n = 340) (n = 50) (n = 290)
Arrest at night, n (%) 218 (64) 29 (58) 189 (65) 0.34
Arrest at the weekend, n (%) 105 (31) 17 (34) 88 (30) 0.62
Arrest location, n (%) 0.69
Intensive care unit 151 (44) 23 (46) 128 (44)
General ward 171 (50) 26 (52) 145 (50)
Others 18 (5) 1 (2) 17 (6)
Witnessed arrest, n (%) 241 (71) 35 (70) 206 (71) 0.87
Monitored status, n (%) 199 (59) 28 (56) 171 (59) 0.76
Shockable rhythm, n (%) 49 (14) 14 (28) 35 (12) 0.007
Critical care interventions in place at time of arrest, n (%)
Mechanical ventilation 64 (19) 7 (14) 57 (20) 0.44
Anti-arrhythmics 30 (9) 5 (10) 25 (9) 0.79
Vasopressors 154 (45) 16 (32) 138 (48) 0.05
Dialysis 23 (7) 2 (4) 21 (7) 0.55
Pulmonary artery catheter 2 (0.6) 2 (4) 0 (0) 0.02
Intra-aortic balloon pumping 1 (0.3) 0 (0) 1 (0.3) 1
Lactate, mmol/L, mean (SD) 9.6 (4.6) 7.2 (4.1) 10.0 (4.5) <0.001
CPR duration, minutes, mean (SD) 28.8 (26.9) 12.4 (12.8) 31.6 (27.7) <0.001
Post-ROSC interventions, n (%)
Extracorporeal membrane oxygenation 20 (6) 3 (6) 17 (6) 1
Therapeutic hypothermia 1 (0.3) 0 (0) 1 (0.3) 1
Percutaneous coronary intervention 8 (2) 3 (6) 5 (2) 0.10
SD standard deviation, CPR cardiopulmonary resuscitation, ROSC return of spontaneous circulation
Table 3 Outcomes after cardiac arrest stratified by lactate levels
Variables All patients, (n = 340)
Number (%)
Lactate level <9 mmol/L, (n = 147)
Number (%)
Lactate level ≧9 mmol/L, (n = 193)
Number (%)
P value
ROSC 242 (71) 109 (74) 133 (69) 0.33
ROSC within 10 minutes of CPR 76 (22) 48 (33) 28 (15) <0.001
ROSC >20 minutes 201 (59) 95 (65) 106 (55) 0.08
Survival >24 hours 129 (38) 76 (52) 53 (28) <0.001
Survival to hospital discharge 50 (15) 34 (23) 16 (8) <0.001
Favourable neurological outcome
at hospital discharge
21 (6) 16 (11) 5 (3) 0.002
ROSC return of spontaneous circulation, CPR cardiopulmonary resuscitation
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create further resuscitation strategies in addition to the
initial conventional CPR.
Excess production of lactate has been reported to be
largely due to tissue hypoxia or hypoperfusion with
associated anaerobic metabolism [22]. For the past few
decades, it has been noted that the blood lactate level
might correlate with the duration of no-flow and low-
flow status during CPR [23, 24], both of which are
known to impact outcomes after cardiac arrest [25]. This
biomarker is therefore a promising candidate for a prog-
nostic predictor of CPR. Weil et al. [11] suggested that
the lactate level measured within 10 minutes of CPR
could be associated with survival outcomes despite the
fact that other important confounders were not consid-
ered during their analysis. In subsequent investigations,
lower serum lactate measurements or early and effective
serum lactate clearance was also shown to correlate with
decreased mortality in cardiac arrest patients [12–18].
These studies [12–18] all used post-ROSC lactate level
for analysis.
In line with previous studies [11–18], we revealed that
the serum lactate level measured during CPR was signifi-
cantly associated with survival outcomes after adjusting
for the confounding effects of multiple factors. There
was a near-linear inverse association between the lactate
level and the probability of survival. Furthermore, a lactate
level <9 mmol/L was significantly associated with higher
survival probabilities. This cutoff point was higher than
those reported in previous studies [15, 16]. Seeger et al.
[15] reported that a lactate level >6.94 mmol/L was asso-
ciated with poor neurological outcomes; Kaji et al. [16]
reported that a lactate level <5 mmol/L correlated with
a favourable neurological outcome. The difference in
threshold values could be explained by the different time
points of lactate measurement and outcome selection.
Compared to measurements after ROSC [15, 16], in which
blood flow had already recovered to ameliorate systemic
hypoxia and hypoperfusion, it seems reasonable that
lactate levels would be higher when measured during
ongoing CPR.
However, the causes of elevated serum lactate do merit
further explanation. Firstly, the serum lactate level could
indeed be a surrogate marker for duration of no-flow
and low-flow status after cardiac arrest [23, 24]. Never-
theless, Müllner et al. also suggested that the lactate
level may be just a weak measure of the duration of car-
diac arrest [26]. For IHCA patients, various conditions,
such as severe septic shock, could also produce similarly
high lactate levels even without cardiac arrest. The use
of adrenaline had also been shown to increase the serum
Table 4 Multiple logistic regression model with survival to
hospital discharge as the dependent variable
Independent variable Odds ratio 95 % Confidence
interval
P value*
CPR duration 0.93 0.90, 0.96 <0.001
Shockable rhythm 2.67 1.18, 5.94 0.02
Hepatic insufficiency 0.29 0.08, 0.82 0.03
Lactate level < 9 mmol/L 2.00 1.01, 4.06 0.05
CPR cardiopulmonary resuscitation
*The display of independent variables is arranged in order of P value.
**Goodness-of-fit assessment: n = 340, adjusted generalized R2 = 0.276, the
estimated area under the receiver operating characteristic curve = 0.817, and
the Hosmer and Lemeshow goodness-of-fit chi-squared test p = 0.19
Fig. 1 Conditional effect plot of duration of cardiopulmonary resuscitation (CPR) on the estimated probability of survival to hospital discharge.
The plot was based on the multiple logistic regression model for survival to hospital discharge
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lactate level [27]. Secondly, the serum lactate level
reflected the difference between lactate production and
elimination; thus, an increased lactate level may also in-
dicate mechanisms other than cellular hypoxia or hypo-
perfusion. For example, impaired liver function could
lead to reduced lactate elimination and an elevated lac-
tate level, even when the hemodynamic status was not
compromised [28, 29]. Despite these considerations, by
adjusting the effects of multiple confounders, including
hepatic insufficiency, we believe that the serum lactate
level measured during CPR, with its complex physiologic
and pathologic implications, could still serve as a useful
prognostic factor for outcomes.
There are currently no recommendations for optimal
CPR duration before transition to the next strategy [3, 4].
In clinical practice, patients usually received a predeter-
mined duration of CPR, often 30 minutes, even if the
patients had not exhibited any response to the repeated
resuscitation efforts. However, for adult IHCA patients,
Goldberger et al. showed that patients would have a
higher probability of survival if they were resuscitated at
hospitals that tended to implement longer CPR durations
[30]. Furthermore, Matos et al. [10] demonstrated that
outcomes after paediatric IHCA could differ significantly
between different patient groups, indicating that surgical
cardiac patients had the highest probability of a good
outcome and trauma patients had the lowest prob-
ability, and that CPR >20 minutes may not be futile
in certain patient groups. Conversely, Kim et al. [31]
recommended that ECPR should be considered for adult
patients with out-of-hospital cardiac arrest (OHCA) when
CPR was ≥21 minutes. In addition, in an adult OHCA
study, Reynolds et al. [32] revealed that the probability of
favourable outcomes declined rapidly with each minute of
CPR and most surviving patients (89.7 %) with favourable
neurological outcomes would achieve ROSC within
16.1 minutes of CPR. Therefore, Reynolds et al. [32] sug-
gested that novel therapeutics, such as ECPR, should be
considered early after CPR rather than after the complete
failure of resuscitation. This could also hold true for IHCA
patients especially for whom applications of ECPR were
more available and mature [7].
Using CPR duration alone to define futile resuscitation
may risk delaying timely implementation of ECPR and
missing opportunities to improve patient outcomes.
However, the classification method of patient groups
used by Matos et al. [10] was somewhat difficult to be
generalized and applied in clinical practice. In our current
study, in addition to serum lactate level and CPR duration,
we also noted that shockable rhythm and hepatic insuffi-
ciency were also significantly associated with survival out-
comes, both of which have also been reported in previous
studies [33, 34]. Based on these variables, we were able to
divide patients into groups with different survival prob-
abilities (Fig. 1). In this way, clinicians may be more pre-
pared for determining the optimal CPR duration for each
patient group before transition to the next strategy, either
a more advanced strategy, such as ECPR, or termination
of CPR.
For example, if we choose the average IHCA survival
rate 18 % as a reference [1, 2], we would note that the
maximally allowed CPR duration was 32.3 minutes for
Table 5 Probability of survival to hospital discharge and duration of cardiopulmonary resuscitation for different patient groups
according to the regression model
Patient groups divided by variables identified in
the regression model
Probability of survival to
hospital discharge when
CPR was performed for
30 minutes
Duration of CPR when
probability of survival to
hospital discharge decreased
to 18 % (minutes)
Duration of CPR when probability
of survival to hospital discharge
was half the initial probability
(minutes)
Group 1: shockable rhythm (+), lactate level <9 mmol/L
(+), hepatic insufficiency (−)
23 % 32.3 21.7
Group 2: shockable rhythm (+), lactate level <9 mmol/L
(−), hepatic insufficiency (−)
13 % 22.2 17.4
Group 3: shockable rhythm (−), lactate level <9 mmol/L
(+), hepatic insufficiency (−)
10 % 17.9 16.0
Group 4: shockable rhythm (+), lactate level < 9 mmol/L
(+), hepatic insufficiency (+)
8 % 14.3 15.1
Group 5: shockable rhythm (−), lactate level < 9 mmol/L
(−), hepatic insufficiency (−)
5 % 7.8 13.8
Group 6: shockable rhythm (+), lactate level <9 mmol/L
(−), hepatic insufficiency (+)
4 % 4.2 13.2
Group 7: shockable rhythm (−), lactate level <9 mmol/L
(+), hepatic insufficiency (+)
3 % NA 12.7
Group 8: shockable rhythm (−), lactate level <9 mmol/l
(−), hepatic insufficiency (+)
2 % NA 12.0
CPR cardiopulmonary resuscitation, NA not available (because the probabilities of survival to hospital discharge for group 7 and 8 were below 18 % from the start
of CPR)
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patient group 1 before the survival probability dropped
below 18 %; however, for patient groups 7 and 8, the sur-
vival probability would be far below 18 % even from the
start of CPR (Table 5). From another perspective, if we
choose the commonly used CPR duration of 30 minutes,
we could note that even if the CPR intervals were the
same, there would be a 10-fold difference in the prob-
ability of survival between patient groups 1 (23 %) and 8
(2 %) (Table 5). Therefore, it is clear that if clinicians
depended solely on CPR duration to define futile resus-
citation, it may be premature to give up for some pa-
tients and delayed to activate alternative resuscitation
measures for other patients. However, because of the
limited number of patients in our analysis, the estima-
tions for CPR duration and survival probability can only
serve for the purpose of explanation rather than precise
estimations.
A lactate level <9 mmol/L was also significantly associ-
ated with a 10-minute ROSC. This CPR interval has
been used as one of prerequisites prior to activation of
ECPR [7] and termination of IHCA CPR [35, 36]. We
suggest that for IHCA patients with a lactate level higher
than 9 mmol/L and without exclusion criteria for ECPR,
the ECPR team should probably be alerted earlier in
order to be able to initiate the ECPR sooner to improve
outcomes, as these patients were shown to have less
chance of achieving rapid ROSC. Conversely, the clinical
decision to terminate IHCA was based solely on witness
status, initial arrest rhythm and CPR duration [35, 36].
Using serum lactate level as an additional variable could
probably increase the accuracy of this decision and avoid
lengthening the dying process of critical patients.
Post-ROSC serum lactate level or the clearance rate of
serum lactate has been associated with neurological out-
comes [12, 14, 16, 17]. An elevated lactate level may rep-
resent a more severe status of tissue hypoperfusion and
ischaemia-reperfusion injury, which might aggravate the
cerebral dysfunction in post-cardiac arrest syndrome
[37]. As there were only 21 patients (6.2 %) in our co-
hort who regained a favourable neurological outcome,
the statistical power may be insufficient to detect the dif-
ference between patients with and without a favourable
neurological outcome. Nonetheless, the trend of the point
estimate of lactate level (odds ratio 1.86) supports our
hypothesis. Future studies with more patients would be
expected to clarify this issue.
In summary, we found that the serum lactate level
measured during CPR was associated with survival out-
comes. Along with other variables, the lactate level could
help separate patients into several groups with different
levels of survival probability. With a predetermined survival
probability, clinicians may be able to determine the optimal
CPR duration for each group. However, in our current
study, we were not aiming to obtain and recommend a
fixed CPR duration for each patient group as this was
dependent on individual patients. We also did not intend
to analyse which strategies should be undertaken follow-
ing implementation of this optimal CPR duration. What
we did emphasize, however, was that the CPR duration
alone should not be used for decision-making in CPR.
The optimal resuscitation strategy should be personalised
and be adjusted to the specific context, taking into ac-
count the autonomy of patients, wishes of family mem-
bers, or the availability of ECPR and other resources of
critical care.
Study limitations
First, this was an observational study, which could only
establish an association rather than a causal relationship
between independent and dependent variables. Second,
the quality of CPR could not be retrospectively deter-
mined. Currently, there were no studies indicating that
the serum lactate level measured during CPR could re-
flect the quality of CPR. The association between serum
lactate level and quality of CPR should be further exam-
ined in a prospective method. Third, we could not be
sure whether the serum lactate was from arterial or ven-
ous samples. Ralston et al. [23] reported that there was
no significant difference in lactate levels between arterial
and venous samples during animal CPR. Therefore, this
issue may not bias our results to a significant extent.
Fourth, the proportion of patients receiving therapeutic
hypothermia was low in our cohort. The influence of
therapeutic hypothermia on the association between
lactate levels and CPR outcomes might be left for future
researchers to investigate. Fifth, we used survival to hos-
pital discharge as the primary outcome because the
number in the studied cohort was small. Nonetheless,
neurologically intact survival might be a more important
and meaningful long-term outcome and should be ex-
plored as the primary outcome in future research with
larger patient populations. Finally, we used IHCA patients
for analysis, and so the results might not be applicaple to
OHCA patients. In addition, the current analysis was a
retrospective study in a single centre with a highly select-
ive cohort, so the probability for selection bias might be
high. The lactate levels measured during the initial 10 mi-
nutes of CPR were only available in 30 % (340/1123) of
the total IHCA patients. Most of the lactate values were
reported simultaneously with measurements of blood
gases or potassium by point-of-care machines. As resusci-
tation guidelines [3, 4] do not suggest the measurement of
lactate level during CPR, only a prospective study could
avoid this kind of selection bias.
Conclusions
The serum lactate level measured during CPR may cor-
relate with survival outcomes. A 9-mmol/L lactate level
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could probably be used as a reference value to identify
patients with different survival probabilities and to de-
termine the optimal duration of CPR.
Key messages
 The serum lactate level measured during CPR may
correlate with survival outcomes
 A 9-mmol/L lactate level could probably be used as
a reference value to identify patients with different
survival probabilities and to determine the optimal
CPR durations
Additional files
Additional file 1: Table S1. Definitions of comorbidities used in the
multivariable models. (DOCX 21 kb)
Additional file 2: Figure S1. Generalized additive model plot for
non-parametric modelling of the effect of serum lactate level on the logit
of probability for survival to hospital discharge. (TIFF 23 kb)
Additional file 3: Table S2. Baseline characteristics of study patients
stratified by lactate level. (DOCX 17 kb)
Additional file 4: Table S3. Features of cardiac arrest events stratified
by lactate level. (DOCX 18 kb)
Additional file 5: Table S4. Multiple logistic regression model with
secondary outcomes as the dependent variable. (DOCX 17 kb)
Abbreviations
CPC: cerebral performance category; CPR: cardiopulmonary resuscitation;
ECPR: extracorporeal cardiopulmonary resuscitation; GAM: generalized
additive model; ICU: intensive care unit; IHCA: in-hospital cardiac arrest;
NTUH: National Taiwan University Hospital; OHCA: out-of-hospital cardiac
arrest; ROSC: rapid return of spontaneous circulation.
Competing interests
The authors declare no conflicts of interest or sources of funding for this
study.
Authors’ contributions
CHW, CHH, WTC and WJC conceived the study and designed the study
protocol. MST and PHY participated in the acquisition of data. CHW, YWW
and KYH conducted the analysis and interpretation of data. CHW drafted the
manuscript in conjunction with the other authors. WJC was responsible for
the critical revision. All authors had full access to all the data in the study
and take responsibility for the integrity of the data and the accuracy of the
data analysis. All authors have read and approved the final version of the
manuscript.
Authors’ information
The corresponding author had full access to all data and final responsibility
to submit the results for publication.
Acknowledgements
We thank Centre of Quality Management of National Taiwan University
Hospital for providing the list of patients sustaining in-hospital cardiac arrest.
This study was funded by the academic research grant NTUHYL.104.S010
from the National Taiwan University Hospital Yunlin Branch, which was not
involved in the study design, in the collection, analysis or interpretation of
data; in the writing of the manuscript; or in the decision to submit the
manuscript for publication.
Author details
1Department of Emergency Medicine, National Taiwan University Hospital
Yunlin Branch, Yunlin, Taiwan. 2Graduate Institute of Clinical Medicine,
College of Medicine, National Taiwan University, Taipei, Taiwan. 3Department
of Emergency Medicine, National Taiwan University Hospital and National
Taiwan University College of Medicine, No.7, Zhongshan S. Rd., Zhongzheng
Dist., Taipei City 100, Taiwan, R.O.C.. 4Department of Emergency Medicine,
Taipei Hospital, Ministry of Health and Welfare, New Taipei City, Taiwan.
5Departments of Internal Medicine and Nuclear Medicine, National Taiwan
University Hospital and National Taiwan University College of Medicine,
Taipei, Taiwan. 6Department of Nuclear Medicine and Cardiology Division of
Cardiovascular Medical Center, Far Eastern Memorial Hospital, New Taipei
City, Taiwan. 7National Yang-Ming University School of Medicine, Taipei,
Taiwan. 8Division of Nephrology, Department of Internal Medicine, National
Taiwan University Hospital, Taipei, Taiwan. 9Department of Emergency
Medicine, Lotung Poh-Ai Hospital, Yilan, Taiwan.
Received: 11 May 2015 Accepted: 30 August 2015
References
1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al.
Heart disease and stroke statistics–2015 update: a report from the American
Heart Association. Circulation. 2015;131:e29–322.
2. Girotra S, Nallamothu BK, Spertus JA, Li Y, Krumholz HM, Chan PS, et al.
Trends in survival after in-hospital cardiac arrest. N Engl J Med.
2012;367:1912–20.
3. Field JM, Hazinski MF, Sayre MR, Chameides L, Schexnayder SM, Hemphill R,
et al. Part 1: executive summary: 2010 American Heart Association
Guidelines for Cardiopulmonary Resuscitation and Emergency
Cardiovascular Care. Circulation. 2010;122:S640–56.
4. Nolan JP, Soar J, Zideman DA, Biarent D, Bossaert LL, Deakin C, et al.
European Resuscitation Council Guidelines for Resuscitation 2010 Section 1.
Executive summary. Resuscitation. 2010;81:1219–76.
5. Travers AH, Rea TD, Bobrow BJ, Edelson DP, Berg RA, Sayre MR, et al.
Part 4: CPR overview: 2010 American Heart Association Guidelines for
Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
Circulation. 2010;122:S676–84.
6. Cave DM, Gazmuri RJ, Otto CW, Nadkarni VM, Cheng A, Brooks SC, et al.
Part 7: CPR techniques and devices: 2010 American Heart Association
Guidelines for Cardiopulmonary Resuscitation and Emergency
Cardiovascular Care. Circulation. 2010;122:S720–8.
7. Chen YS, Lin JW, Yu HY, Ko WJ, Jerng JS, Chang WT, et al. Cardiopulmonary
resuscitation with assisted extracorporeal life-support versus conventional
cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an
observational study and propensity analysis. Lancet. 2008;372:554–61.
8. Fagnoul D, Combes A, De Backer D. Extracorporeal cardiopulmonary
resuscitation. Curr Opin Crit Care. 2014;20:259–65.
9. Conseil français de réanimation cardiopulmonaire; Société française
d'anesthésie et de réanimation; Société française de cardiologie; Société
française de chirurgie thoracique et cardiovasculaire; Société française de
médecine d'urgence; Société française de pédiatrie, et al. Guidelines for
indications for the use of extracorporeal life support in refractory cardiac
arrest. French Ministry of Health. Ann Fr Anesth Reanim. 2009;28:182–90.
10. Matos RI, Watson RS, Nadkarni VM, Huang HH, Berg RA, Meaney PA, et al.
Duration of cardiopulmonary resuscitation and illness category impact
survival and neurologic outcomes for in-hospital pediatric cardiac arrests.
Circulation. 2013;127:442–51.
11. Weil MH, Ruiz CE, Michaels S, Rackow EC. Acid–base determinants of
survival after cardiopulmonary resuscitation. Crit Care Med. 1985;13:888–92.
12. Donnino MW, Andersen LW, Giberson T, Gaieski DF, Abella BS, Peberdy MA,
et al. Initial lactate and lactate change in post-cardiac arrest: a multicenter
validation study. Crit Care Med. 2014;42:1804–11.
13. Starodub R, Abella BS, Grossestreuer AV, Shofer FS, Perman SM, Leary M, et
al. Association of serum lactate and survival outcomes in patients
undergoing therapeutic hypothermia after cardiac arrest. Resuscitation.
2013;84:1078–82.
14. Kliegel A, Losert H, Sterz F, Holzer M, Zeiner A, Havel C, et al. Serial lactate
determinations for prediction of outcome after cardiac arrest. Medicine
(Baltimore). 2004;83:274–9.
15. Seeger FH, Toenne M, Lehmann R, Ehrlich JR. Simplistic approach to
prognosis after cardiopulmonary resuscitation-value of pH and lactate.
J Crit Care. 2013;28:317. e13-20.
Wang et al. Critical Care  (2015) 19:344 Page 8 of 9
16. Kaji AH, Hanif AM, Bosson N, Ostermayer D, Niemann JT. Predictors of
neurologic outcome in patients resuscitated from out-of-hospital cardiac
arrest using classification and regression tree analysis. Am J Cardiol.
2014;114:1024–8.
17. Lee TR, Kang MJ, Cha WC, Shin TG, Sim MS, Jo IJ, et al. Better lactate
clearance associated with good neurologic outcome in survivors who
treated with therapeutic hypothermia after out-of-hospital cardiac arrest.
Crit Care. 2013;17:R260.
18. Donnino MW, Miller J, Goyal N, Loomba M, Sankey SS, Dolcourt B, et al.
Effective lactate clearance is associated with improved outcome in
post-cardiac arrest patients. Resuscitation. 2007;75:229–34.
19. Jacobs I, Nadkarni V, Bahr J, Berg RA, Billi JE, Bossaert L, et al. Cardiac arrest
and cardiopulmonary resuscitation outcome reports: update and
simplification of the Utstein templates for resuscitation registries: a
statement for healthcare professionals from a task force of the International
Liaison Committee on Resuscitation (American Heart Association, European
Resuscitation Council, Australian Resuscitation Council, New Zealand
Resuscitation Council, Heart and Stroke Foundation of Canada,
InterAmerican Heart Foundation, Resuscitation Councils of Southern Africa).
Circulation. 2004;110:3385–97.
20. Becker LB, Aufderheide TP, Geocadin RG, Callaway CW, Lazar RM,
Donnino MW, et al. Primary outcomes for resuscitation science studies: a
consensus statement from the American Heart Association. Circulation.
2011;124:2158–77.
21. Hastie TJ, Tibshirani RJ. Generalized Additive Models. 1st ed. London and
New York: Chapman & Hall; 1990.
22. Bernardin G, Pradier C, Tiger F, Deloffre P, Mattei M. Blood pressure and
arterial lactate level are early indicators of short-term survival in human
septic shock. Intensive Care Med. 1996;22:17–25.
23. Ralston SH, Voorhees WD, Showen L, Schmitz P, Kougias C, Tacker WA.
Venous and arterial blood gases during and after cardiopulmonary
resuscitation in dogs. Am J Emerg Med. 1985;3:132–6.
24. Carden DL, Martin GB, Nowak RM, Foreback CC, Tomlanovich MC.
Lactic acidosis during closed-chest CPR in dogs. Ann Emerg Med.
1987;16:1317–20.
25. Adrie C, Cariou A, Mourvillier B, Laurent I, Dabbane H, Hantala F, et al.
Predicting survival with good neurological recovery at hospital admission
after successful resuscitation of out-of-hospital cardiac arrest: the OHCA
score. Eur Heart J. 2006;27:2840–5.
26. Müllner M, Sterz F, Domanovits H, Behringer W, Binder M, Laggner AN. The
association between blood lactate concentration on admission, duration of
cardiac arrest, and functional neurological recovery in patients resuscitated
from ventricular fibrillation. Intensive Care Med. 1997;23:1138–43.
27. Grip J, Jakobsson T, Hebert C, Klaude M, Sandström G, Wernerman J, et al.
Lactate kinetics and mitochondrial respiration in skeletal muscle of healthy
humans under influence of adrenaline. Clin Sci (Lond). 2015;129:375–84.
28. Jeppesen JB, Mortensen C, Bendtsen F, Møller S. Lactate metabolism in
chronic liver disease. Scand J Clin Lab Invest. 2013;73:293–9.
29. De Jonghe B, Cheval C, Misset B, Timsit JF, Garrouste M, Montuclard L, et al.
Relationship between blood lactate and early hepatic dysfunction in acute
circulatory failure. J Crit Care. 1999;14:7–11.
30. Goldberger ZD, Chan PS, Berg RA, Kronick SL, Cooke CR, Lu M, et al.
Duration of resuscitation efforts and survival after in-hospital cardiac arrest:
an observational study. Lancet. 2012;380:1473–81.
31. Kim SJ, Jung JS, Park JH, Park JS, Hong YS, Lee SW. An optimal transition
time to extracorporeal cardiopulmonary resuscitation for predicting good
neurological outcome in patients with out-of-hospital cardiac arrest: a
propensity-matched study. Crit Care. 2014;18:535.
32. Reynolds JC, Frisch A, Rittenberger JC, Callaway CW. Duration of
resuscitation efforts and functional outcome after out-of-hospital cardiac
arrest: when should we change to novel therapies? Circulation.
2013;128:2488–94.
33. Chan PS, Spertus JA, Krumholz HM, Berg RA, Li Y, Sasson C, et al. A validated
prediction tool for initial survivors of in-hospital cardiac arrest. Arch Intern
Med. 2012;172:947–53.
34. Ebell MH, Jang W, Shen Y, Geocadin RG, Get With the Guidelines–
Resuscitation Investigators. Development and validation of the Good
Outcome Following Attempted Resuscitation (GO-FAR) score to predict
neurologically intact survival after in-hospital cardiopulmonary resuscitation.
JAMA Intern Med. 2013;173:1872–8.
35. van Walraven C, Forster AJ, Stiell IG. Derivation of a clinical decision rule for
the discontinuation of in-hospital cardiac arrest resuscitations. Arch Intern
Med. 1999;159:129–34.
36. van Walraven C, Forster AJ, Parish DC, Dane FC, Chandra KM, Durham MD,
et al. Validation of a clinical decision aid to discontinue in-hospital cardiac
arrest resuscitations. JAMA. 2001;285:1602–6.
37. Nolan JP, Neumar RW, Adrie C, Aibiki M, Berg RA, Böttiger BW, et al.
Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment,
and prognostication. A Scientific Statement from the International Liaison
Committee on Resuscitation; the American Heart Association Emergency
Cardiovascular Care Committee; the Council on Cardiovascular Surgery and
Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical
Care; the Council on Clinical Cardiology; the Council on Stroke.
Resuscitation. 2008;79:350–79.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Wang et al. Critical Care  (2015) 19:344 Page 9 of 9
